Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
暂无分享,去创建一个
Robin L. Jones | J. Blay | S. Litière | M. Guida | J. Šufliarský | P. Rutkowski | H. Gelderblom | S. Stacchiotti | B. Vincenzi | N. Steeghs | G. Grignani | A. Constantinidou | N. Hindi | I. Desar | Alexander Klein | N. Sauvé | Valentin Thibaud
[1] P. Rutkowski,et al. The final outcomes of study on combined therapy of adult patients with localized synovial sarcoma , 2019, Annals of Oncology.
[2] Robin L. Jones,et al. Results of the TAPPAS trial: An adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS) , 2019, Annals of Oncology.
[3] Robin L. Jones,et al. Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours , 2019, European journal of cancer.
[4] David C. Smith,et al. Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours , 2017 .
[5] J. Blay,et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. , 2017, The Lancet. Oncology.
[6] Robin L. Jones,et al. Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis , 2017, Acta oncologica.
[7] D. Fraker,et al. A prognostic model for resectable soft tissue and cutaneous angiosarcoma , 2016, Journal of surgical oncology.
[8] J. Blay,et al. Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J. Kane,et al. Neoadjuvant chemotherapy for primary cutaneous/soft tissue angiosarcoma: Determining tumor behavior prior to surgical resection , 2015, Journal of surgical oncology.
[10] E. Wardelmann,et al. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials. , 2014, European journal of cancer.
[11] B. Longley,et al. Angiosarcoma Outcomes and Prognostic Factors: A 25-Year Single Institution Experience , 2014, American journal of clinical oncology.
[12] M. W. Kolff,et al. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. , 2014, European journal of cancer.
[13] C. Fletcher. The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification , 2014, Histopathology.
[14] M. Reed,et al. Vascular-targeted agents for the treatment of angiosarcoma , 2014, Cancer Chemotherapy and Pharmacology.
[15] M. von Mehren,et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] J. Blay,et al. Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO). , 2012, The oncologist.
[17] A. D. Dei Tos,et al. Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] J. Blay,et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] E. Sturgis,et al. Neoadjuvant chemotherapy–specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement , 2008, Head & neck.
[20] J. Blay,et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] D. Kirsch,et al. Treatment and Outcome of 82 Patients with Angiosarcoma , 2007, Annals of Surgical Oncology.
[22] C. Antonescu,et al. A 14‐Year Retrospective Review of Angiosarcoma: Clinical Characteristics, Prognostic Factors, and Treatment Outcomes with Surgery and Chemotherapy , 2005, Cancer journal.
[23] V. Sondak,et al. Cutaneous angiosarcoma of the scalp , 2003, Cancer.
[24] J. Poen,et al. Angiosarcoma: A report of 67 patients and a review of the literature , 1996, Cancer.